Preoperative C-Reactive Protein/Albumin Ratio is a Prognostic Indicator for Survival in Surgically Treated Gastrointestinal Stromal Tumors: A Retrospective Cohort Study

References

• Patel N , Benipal B . Incidence of Gastrointestinal Stromal Tumors in the United States from 2001–2015: a United States Cancer Statistics Analysis of 50 States. Cureus . 2019;11(2):e4120. doi:10.7759/cureus.4120 31037234
   PubMed Web of Science ®Google Scholar
• Li J , Shen L . The current status of and prospects in research regarding gastrointestinal stromal tumors in China. Cancer . 2020;126 Suppl 9:2048–2053. doi:10.1002/cncr.32684 32293728
   PubMed Web of Science ®Google Scholar
• Etherington MS , DeMatteo RP . Tailored management of primary gastrointestinal stromal tumors. Cancer . 2019;125(13):2164–2171. doi:10.1002/cncr.32067 30933313
   PubMed Web of Science ®Google Scholar
• Akahoshi K , Oya M , Koga T , Shiratsuchi Y . Current clinical management of gastrointestinal stromal tumor. World j Gastroenterol . 2018;24(26):2806–2817. doi:10.3748/wjg.v24.i26.2806 30018476
   PubMed Web of Science ®Google Scholar
• Fletcher CD , Berman JJ , Corless C , et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol . 2002;33(5):459–465. doi:10.1053/hupa.2002.123545 12094370
   PubMed Web of Science ®Google Scholar
• Agaimy A . Gastrointestinal stromal tumors (GIST) from risk stratification systems to the new TNM proposal: more questions than answers? A review emphasizing the need for a standardized GIST reporting. Int J Clin Exp Pathol . 2010;3(5):461–471.20606727
   PubMed Web of Science ®Google Scholar
• Sobin LH , Compton CC . TNM seventh edition: what’s new, what’s changed: communication from the International Union Against Cancer and the American Joint Committee on Cancer. Cancer . 2010;116(22):5336–5339. doi:10.1002/cncr.25537 20665503
   PubMed Web of Science ®Google Scholar
• Joensuu H . Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Hum Pathol . 2008;39(10):1411–1419. doi:10.1016/j.humpath.2008.06.025 18774375
   PubMed Web of Science ®Google Scholar
• Miettinen M , Lasota J . Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol . 2006;23(2):70–83. doi:10.1053/j.semdp.2006.09.001 17193820
   PubMed Web of Science ®Google Scholar
• Gold JS , Gönen M , Gutiérrez A , et al. Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis. Lancet Oncol . 2009;10(11):1045–1052. doi:10.1016/s1470-2045(09)70242-6 19793678
   PubMed Web of Science ®Google Scholar
• McDowell SAC , Quail DF . Immunological Regulation of Vascular Inflammation During Cancer Metastasis. Front Immunol . 2019;10:1984. doi:10.3389/fimmu.2019.01984 31497019
   PubMed Web of Science ®Google Scholar
• Fonseca GW , Farkas J , Dora E . Cancer Cachexia and Related Metabolic Dysfunction. Int J Mol Sci . 2020;21(7). doi:10.3390/ijms21072321
   Web of Science ®Google Scholar
• Tuomisto AE , Mäkinen MJ , Väyrynen JP . Systemic inflammation in colorectal cancer: underlying factors, effects, and prognostic significance. World j Gastroenterol . 2019;25(31):4383–4404. doi:10.3748/wjg.v25.i31.4383 31496619
   PubMed Web of Science ®Google Scholar
• Dupré A , Malik HZ . Inflammation and cancer: what a surgical oncologist should know. Eur j Surgical Oncol . 2018;44(5):566–570. doi:10.1016/j.ejso.2018.02.209
   PubMed Web of Science ®Google Scholar
• Jagadesham VP , Lagarde SM , Immanuel A , Griffin SM . Systemic inflammatory markers and outcome in patients with locally advanced adenocarcinoma of the oesophagus and gastro-oesophageal junction. Br J Surg . 2017;104(4):401–407. doi:10.1002/bjs.10425 28072456
   PubMed Web of Science ®Google Scholar
• Gunnarsson U , Strigård K , Edin S . Association between local immune cell infiltration, mismatch repair status and systemic inflammatory response in colorectal cancer. J Transl Med . 2020;18(1):178. doi:10.1186/s12967-020-02336-6 32316975
   PubMed Web of Science ®Google Scholar
• Zhang K , Hua Y-Q , Wang D . Systemic immune-inflammation index predicts prognosis of patients with advanced pancreatic cancer. J Transl Med . 2019;17(1):30. doi:10.1186/s12967-019-1782-x 30658662
   PubMed Web of Science ®Google Scholar
• Fonseca GW , Farkas J , Dora E . Serum interleukin-6 and C-reactive protein are associated with survival in melanoma patients receiving immune checkpoint inhibition. J Immunotherapy Cancer . 2020;8. doi:10.1136/jitc-2020-000842
   Web of Science ®Google Scholar
• Baitar A , Kenis C , Decoster L . The prognostic value of 3 commonly measured blood parameters and geriatric assessment to predict overall survival in addition to clinical information in older patients with cancer. Cancer . 2018;124(18):3764–3775. doi:10.1002/cncr.31580 30298906
   PubMed Web of Science ®Google Scholar
• Chan SL , Chan AWH , Chan AKC . Systematic evaluation of circulating inflammatory markers for hepatocellular carcinoma. Liver Int . 2017;37(2):280–289. doi:10.1111/liv.13218 27501075
   PubMed Web of Science ®Google Scholar
• Dolan RD , McMillan DC . The prevalence of cancer associated systemic inflammation: implications of prognostic studies using the Glasgow Prognostic Score. Crit Rev Oncol Hematol . 2020;150:102962. doi:10.1016/j.critrevonc.2020.102962 32344318
   PubMed Web of Science ®Google Scholar
• McSorley ST , Black DH , Horgan PG , McMillan DC . The relationship between tumour stage, systemic inflammation, body composition and survival in patients with colorectal cancer. Clin nutrition . 2018;37(4):1279–1285. doi:10.1016/j.clnu.2017.05.017
   PubMed Web of Science ®Google Scholar
• Arigami T , Uenosono Y , Ishigami S . Clinical significance of the glasgow prognostic score in patients with gastrointestinal stromal tumors. Anticancer Res . 2016;36(12):6687–6690. doi:10.21873/anticanres.11279 27920003
   PubMed Web of Science ®Google Scholar
• Ishibashi Y , Tsujimoto H , Einama T . Correlation Between Immunoinflammatory Measures and Periostin Expression in Esophageal Squamous Cell Carcinoma: a Single-Center, Retrospective Cohort Study. Ann Surg Oncol . 2020. doi:10.1245/s10434-020-08765-3
   Web of Science ®Google Scholar
• Kudou K , Saeki H , Nakashima Y . C-reactive protein/albumin ratio is a poor prognostic factor of esophagogastric junction and upper gastric cancer. J Gastroenterol Hepatol . 2019;34(2):355–363. doi:10.1111/jgh.14442 30119141
   PubMed Web of Science ®Google Scholar
• Ishizuka M , Nagata H , Takagi K , Iwasaki Y , Shibuya N , Kubota K . Clinical Significance of the C-Reactive Protein to Albumin Ratio for Survival After Surgery for Colorectal Cancer. Ann Surg Oncol . 2016;23(3):900–907. doi:10.1245/s10434-015-4948-7 26530445
   PubMed Web of Science ®Google Scholar
• Li J , Ye Y , Wang J , et al. Chinese consensus guidelines for diagnosis and management of gastrointestinal stromal tumor. Chine j Cancer Res . 2017;29(4):281–293. doi:10.21147/j.issn.1000-9604.2017.04.01
   PubMed Web of Science ®Google Scholar
• Sankar A , Johnson S , Beattie W , Tait G , Wijeysundera D . Reliability of the American Society of Anesthesiologists physical status scale in clinical practice. Br J Anaesth . 2014;113(3):424–432. doi:10.1093/bja/aeu100 24727705
   PubMed Web of Science ®Google Scholar
• McMillan D . The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer Treat Rev . 2013;39(5):534–540. doi:10.1016/j.ctrv.2012.08.003 22995477
   PubMed Web of Science ®Google Scholar
• Njunge L , Estania A , Guo Y , Liu W , Yang L . Tumor progression locus 2 (TPL2) in tumor-promoting Inflammation, Tumorigenesis and Tumor Immunity. Theranostics . 2020;10(18):8343–8364. doi:10.7150/thno.45848 32724474
   PubMed Web of Science ®Google Scholar
• Hamarsheh S , Zeiser R . NLRP3 Inflammasome Activation in Cancer: a Double-Edged Sword. Front Immunol . 2020;11:1444. doi:10.3389/fimmu.2020.01444 32733479
   PubMed Web of Science ®Google Scholar
• Tuomisto A , Mäkinen M , Väyrynen J . Systemic inflammation in colorectal cancer: underlying factors, effects, and prognostic significance. World j Gastroenterol . 2019;25(31):4383–4404. doi:10.3748/wjg.v25.i31.4383 31496619
   PubMed Web of Science ®Google Scholar
• Bruserud O , Aarstad H , Combined C-Reactive TT . Protein and novel inflammatory parameters as a predictor in cancer-what can we learn from the hematological experience? Cancers . 2020;12(7):1966. doi:10.3390/cancers12071966
   PubMed Web of Science ®Google Scholar
• Aarstad H , Guðbrandsdottir G , Hjelle K , et al. The biological context of C-reactive protein as a prognostic marker in renal cell carcinoma: studies on the acute phase cytokine profile. Cancers . 2020;12(7):1961. doi:10.3390/cancers12071961
   PubMed Web of Science ®Google Scholar
• Almasaudi A , Dolan R , Edwards C , McMillan D . Hypoalbuminemia Reflects nutritional risk, body composition and systemic inflammation and is independently associated with survival in patients with colorectal cancer. Cancers . 2020;12(7):1986. doi:10.3390/cancers12071986
   PubMed Web of Science ®Google Scholar
• Park J , Watt D , Roxburgh C , Horgan P , Colorectal Cancer MD , Inflammation S . Outcome: staging the Tumor and Staging the Host. Ann Surg . 2016;263(2):326–336. doi:10.1097/sla.0000000000001122 25575264
   PubMed Web of Science ®Google Scholar
• Xu B , Lu J , Zheng Z , et al. The predictive value of the preoperative C-reactive protein-albumin ratio for early recurrence and chemotherapy benefit in patients with gastric cancer after radical gastrectomy: using randomized Phase III trial data. Gastric Cancer . 2019;22(5):1016–1028. doi:10.1007/s10120-019-00936-w 30739259
   PubMed Web of Science ®Google Scholar
• Ranzani O , Zampieri F , Forte D , Azevedo L , Park M . C-reactive protein/albumin ratio predicts 90-day mortality of septic patients. PLoS One . 2013;8(3):e59321. doi:10.1371/journal.pone.0059321 23555017
   PubMed Web of Science ®Google Scholar
• Chen J , Fang A , Chen M , et al. A novel inflammation-based nomogram system to predict survival of patients with hepatocellular carcinoma. Cancer Med . 2018;7(10):5027–5035. doi:10.1002/cam4.1787 30259688
   PubMed Web of Science ®Google Scholar
• Xu HJ , Ma Y , Deng F , Ju WB , Sun XY , Wang H . The prognostic value of C-reactive protein/albumin ratio in human malignancies: an updated meta-analysis. Onco Targets Ther . 2017;10:3059–3070. doi:10.2147/ott.S137002 28790840
   PubMed Web of Science ®Google Scholar
• Kudou K , Saeki H , Nakashima Y , et al. C-reactive protein/albumin ratio is a poor prognostic factor of esophagogastric junction and upper gastric cancer. J Gastroenterol Hepatol . 2019;34(2):355–363. doi:10.1111/jgh.14442 30119141
   PubMed Web of Science ®Google Scholar
• Liu X , Sun X , Liu J , et al. Preoperative C-Reactive Protein/Albumin Ratio Predicts Prognosis of Patients after Curative Resection for Gastric Cancer. Transl Oncol . 2015;8(4):339–345. doi:10.1016/j.tranon.2015.06.006 26310380
   PubMed Web of Science ®Google Scholar
• Arigami T , Uenosono Y , Ishigami S , et al. Clinical Significance of the Glasgow Prognostic Score in Patients with Gastrointestinal Stromal Tumors. Anticancer Res . 2016;36(12):6687–6690. doi:10.21873/anticanres.11279 27920003
   PubMed Web of Science ®Google Scholar
• Toyokawa T , Muguruma K , Yoshii M , et al. Clinical significance of prognostic inflammation-based and/or nutritional markers in patients with stage III gastric cancer. BMC Cancer . 2020;20(1):517. doi:10.1186/s12885-020-07010-0 32493247
   PubMed Web of Science ®Google Scholar
• Kunzelmann K , Ousingsawat J , Benedetto R , Cabrita I , Schreiber R . Contribution of Anoctamins to Cell Survival and Cell Death. Cancers . 2019;11:3. doi:10.3390/cancers11030382
   Web of Science ®Google Scholar
• Tan Y , Trent J , Wilky B , Kerr D , Rosenberg A . Current status of immunotherapy for gastrointestinal stromal tumor. Cancer Gene Ther . 2017;24(3):130–133. doi:10.1038/cgt.2016.58 28186088
   PubMed Web of Science ®Google Scholar
• Hompland I , Ø B , Hølmebakk T , et al. Prediction of long-term survival in patients with metastatic gastrointestinal stromal tumor: analysis of a large, single-institution cohort. Acta oncologica . 2017;56(10):1317–1323. doi:10.1080/0284186x.2017.1330555 28557540
   PubMed Web of Science ®Google Scholar
• Jung A , Roh J , Kim J , et al. Prognostic value of body composition on recurrence and survival of advanced-stage head and neck cancer. Eur j Cancer . 2019;116:98–106. doi:10.1016/j.ejca.2019.05.006 31185387
   PubMed Web of Science ®Google Scholar